发明名称 Morpholinobenzamide salts
摘要 The present invention relates to pharmaceutically acceptable salts of the compound of formula I or solvates of said salt in which the compound of formula I is as the (R)-enantiomer, the (S)-enantiomer or the racemate,a process for their preparation, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy.
申请公布号 US6291458(B1) 申请公布日期 2001.09.18
申请号 US20000621387D 申请日期 2000.07.21
申请人 ASTRAZENECA AB 发明人 BERG STEFAN;SOHN DANIEL
分类号 C07D295/14;A61K;A61K31/496;A61K31/5377;A61P;A61P1/14;A61P3/04;A61P5/00;A61P7/02;A61P9/00;A61P9/12;A61P13/02;A61P15/00;A61P25/00;A61P25/04;A61P25/06;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/34;A61P29/00;A61P35/00;A61P43/00;C07C;C07D;C07D295/135;C07D295/155;C07D413/12;C07D413/14;(IPC1-7):A61K31/537 主分类号 C07D295/14
代理机构 代理人
主权项
地址